- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1,430)
18 result(s) found for: TEC.
Displaying page 1 of 1.
EudraCT Number: 2021-002531-27 | Sponsor Protocol Number: EMN30/64007957MMY3003 | Start Date*: 2022-04-11 | |||||||||||
Sponsor Name:European Myeloma Network (EMN) | |||||||||||||
Full Title: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following ... | |||||||||||||
Medical condition: Newly Diagnosed Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Trial now transitioned) IT (Trial now transitioned) NO (Trial now transitioned) DE (Trial now transitioned) DK (Trial now transitioned) NL (Trial now transitioned) AT (Trial now transitioned) BE (Trial now transitioned) CZ (Trial now transitioned) IE (Trial now transitioned) FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022739-13 | Sponsor Protocol Number: TEC | Start Date*: 2011-01-03 |
Sponsor Name:Institut de Recerca HSCSP | ||
Full Title: Estudio comparativo de 2 pautas anestésicas en TEC: Repercusión hemodinámica y duración de la convulsión. | ||
Medical condition: Pacientes psiquiatricos subsidiarios de terapia electroconvulsiva. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000909-28 | Sponsor Protocol Number: 64007957MMY3005 | Start Date*: 2022-09-05 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination with Daratumumab SC and Lenalidomide (Tal-DR) versus Dar... | |||||||||||||
Medical condition: Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) NL (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) PT (Trial now transitioned) DE (Trial now transitioned) CZ (Ongoing) AT (Trial now transitioned) NO (Trial now transitioned) PL (Trial now transitioned) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001594-31 | Sponsor Protocol Number: 2022_0174 | Start Date*: 2022-08-30 | |||||||||||
Sponsor Name:CHU de LILLE | |||||||||||||
Full Title: A Phase 2 Study of Teclistamab in Combination with Daratumumab or Lenalidomide in Elderly Patients with Newly Diagnosed Multiple Myeloma | |||||||||||||
Medical condition: A Phase 2 Study of Teclistamab in Combination with Daratumumab or Lenalidomide in Elderly Patients with Newly Diagnosed Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004742-11 | Sponsor Protocol Number: 64007957MMY3001 | Start Date*: 2021-10-05 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexame... | |||||||||||||
Medical condition: Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) ES (Ongoing) DK (Trial now transitioned) NL (Trial now transitioned) GR (Trial now transitioned) IT (Trial now transitioned) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000598-15 | Sponsor Protocol Number: GEM-TECTAL | Start Date*: 2023-01-12 | |||||||||||
Sponsor Name:PETHEMA Foundation | |||||||||||||
Full Title: An open label, multicenter, Phase 2, pilot study, evaluating early treatment with bispecific T-cell redirectors (teclistamab and talquetamab) in the front line therapy of newly diagnosed high -risk... | |||||||||||||
Medical condition: Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005162-34 | Sponsor Protocol Number: clinical_study_protocol | Start Date*: 2017-05-19 | |||||||||||
Sponsor Name:University Hospital Basel | |||||||||||||
Full Title: Randomized, multi-center phase II clinical trial for the regeneration of cartilage lesions in the knee using nasal chondrocyte-based tissue (NTEC) or nasal chondrocyte-based cell (N-CAM)-therapies | |||||||||||||
Medical condition: Patients must display 1-2 symptomatic, focal cartilage lesion grade IIIIV (according to the grading by the International Cartilage Repair Society (ICRS)) from 2 to 8 cm2 on the femoral condyle and/... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000396-14 | Sponsor Protocol Number: 3/006/11 | Start Date*: 2011-06-15 | |||||||||||||||||||||
Sponsor Name:University of Aberdeen [...] | |||||||||||||||||||||||
Full Title: The use of Ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome? | |||||||||||||||||||||||
Medical condition: Depression. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003064-19 | Sponsor Protocol Number: NeoTEC | Start Date*: 2008-12-30 | |||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||
Full Title: Phase-IIb-Study to Evaluate the Effect of a Neoadjuvant Chemotherapy with Docetaxel, Epirubicine and Cyclphosphamide (TEC) in Patients with primary HER-2 neu Negative Mammacarcinoma | |||||||||||||
Medical condition: Primary mamma carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000824-12 | Sponsor Protocol Number: B7981031 | Start Date*: 2023-09-06 |
Sponsor Name:Pfizer, Inc. | ||
Full Title: AN INTERVENTIONAL PK, PD, PHASE 1, OPEN-LABEL STUDY TO INVESTIGATE PK AND PD OF MULTIPLE-DOSE RITLECITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA | ||
Medical condition: Alopecia Areata | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2019-003645-16 | Sponsor Protocol Number: 2019_0012 | Start Date*: 2020-02-25 |
Sponsor Name:Hopital Foch | ||
Full Title: Benefit of the GnRH agonist before frozen embryo transfer in patients with endometriosis and / or adenomyosis: randomized prospective study | ||
Medical condition: Frozen embryo transfer in patients with endometriosis and/or adenomyosis | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007166-37 | Sponsor Protocol Number: TECHUB2007 | Start Date*: 2009-02-04 | |||||||||||
Sponsor Name:MIKEL URRETAVIZCAYA SARACHAGA | |||||||||||||
Full Title: “TERAPIA ELECTROCONVULSIVA DE CONSOLIDACIÓN ASOCIADA A PSICOFÁRMACOS VERSUS FARMACOTERAPIA EN LA PREVENCIÓN DE RECIDIVAS EN EL TRASTORNO DEPRESIVO MAYOR. UN ENSAYO CLÍNICO, PRAGMÁTICO, PROSPECTIVO ... | |||||||||||||
Medical condition: TRASTORNO DEPRESIVO MAYOR | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002429-37 | Sponsor Protocol Number: NSGO-EC-9501 Amendment 2 | Start Date*: 2004-11-17 |
Sponsor Name:Nordic Society for Gynecologic Oncology | ||
Full Title: A randomized trial of adjuvant treatment with radiation plus chemotherapy versus radiation alone in high-risk endometrial carcinoma NSGO-EC-9501 Amendment 2. | ||
Medical condition: Endometrial cancer stage I-III radically operated with high-risk factors (high-grade and deep myometrial infiltration, or serous or clear cell histology) that will receive adjuvant treatment with r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003784-19 | Sponsor Protocol Number: RJ-CPX01 | Start Date*: 2017-07-21 | |||||||||||
Sponsor Name:Laboratorio Reig Jofre, SA | |||||||||||||
Full Title: Phase III, multicentre, randomised, double blind, parallel-group, clinical trial to evaluate the efficacy and safety of a new medicated nail lacquer for the treatment of toenail fungal infection | |||||||||||||
Medical condition: toenail onychomycosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001186-12 | Sponsor Protocol Number: GMMG-HD10/DSMM-XX/64007957MMY2003 | Start Date*: 2022-11-07 | |||||||||||
Sponsor Name:Ruprecht-Karls-University Heidelberg, Medical Faculity, represented by University Hospital Heidelberg | |||||||||||||
Full Title: A Phase 2 Study to Evaluate Safety and Efficacy of Teclistamab- and Talquetamab-based Combination Regimens in Participants with Newly Diagnosed Transplant Eligible Multiple Myeloma | |||||||||||||
Medical condition: Newly Diagnosed Multiple Myeloma in patients eligible for stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001399-40 | Sponsor Protocol Number: RECHMPL20_0092 | Start Date*: 2021-06-02 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Amlodipine interest in HRT (Hormone Replacement Therapy) cycle for frozen embryo transfer in the uterine pulsatility indices correction: double-blind randomized controlled trial | ||
Medical condition: uterine arteries pulsalility index for patients awaiting frozen embryo transfer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003965-21 | Sponsor Protocol Number: 20VADS04 | Start Date*: 2021-01-11 | |||||||||||
Sponsor Name:INSTITUT CLAUDIUS REGAUD | |||||||||||||
Full Title: Phase II Randomized Controlled Study Aiming to Evaluate the Interest of Qutenza in Patients With ORL Cancer in Remission and With Sequellae Neuropathic Pain. | |||||||||||||
Medical condition: Head and neck cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003942-35 | Sponsor Protocol Number: APHP200018 | Start Date*: 2021-04-27 | |||||||||||
Sponsor Name:Assistance Publique - Hôpitaux Paris | |||||||||||||
Full Title: HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency | |||||||||||||
Medical condition: Critically ill patients with a SOFA score (SOFA; Sequential Organ Failure Assessment) ≥ 6, for at least 6 consecutive hours, suffering from CIRCI, to the notable exception of patients with septic s... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
